6 completed. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 2 | Completed 2 |
Follow opigolix: new trials by email Literature Review of opigolix trials Research Report on opigolix
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of ASP1707 in Postmenopausal Female Patients With Rheumatoid Arthritis Taking Methotrexate ASP1707, Placebo, Methotrexate - Rheumatoid Arthritis | Phase 2 | Completed | Astellas Pharma Inc | 72 | 2016-09-16 | 2024-10-23 |
| A Study to Evaluate the Pharmacokinetics of ASP1707 and Methotrexate in Patients With Rheumatoid Arthritis ASP1707, methotrexate (MTX) - Rheumatoid Arthritis | Phase 1 | Completed | Astellas Pharma Global Development, Inc. | 10 | 2016-07-25 | 2024-10-23 |
| A Study to Assess the Interaction Between ASP1707 and Itraconazole in Healthy Female Subjects ASP1707, itraconazole - Pharmacokinetics, DDI (Drug-Drug Interaction) | Phase 1 | Completed | Astellas Pharma Europe B.V. | 14 | 2014-04-01 | 2014-07-03 |
| A Study to Assess the Effectiveness and Safety of Different Doses of ASP1707 Compared to Placebo for Endometriosis Associated Pelvic Pain ASP1707, Placebo, Leuprorelin acetate - Endometriosis | Phase 2 | Completed | Astellas Pharma Europe B.V. | 912 | 2012-12-04 | 2024-10-23 |
| A Study to Assess the Effects of Single Ascending Doses of ASP1707 in Healthy Young Japanese Male Subjects ASP1707, Placebo - Healthy Subjects | Phase 1 | Completed | Astellas Pharma Europe B.V. | 24 | 2011-06-01 | 2014-05-26 |
| A Study to Assess the Safety, Tolerability and Effects of Single and Multiple Ascending Doses of ASP1707 in Healthy Male and Pre-menopausal Female Subjects, Including a Comparison of the Effects Under Fasted and Fed Conditions in Healthy Young Male Subjects ASP1707 single dose of dose levels 1 -7, Placebo single dose of dose levels 1-7, ASP1707 single dose fasted - Pharmacokinetics of ASP1707, Pharmacodynamics of ASP1707 | Phase 1 | Completed | Astellas Pharma Europe B.V. | 176 | 2010-06-01 | 2015-02-23 |
Arthritis, Rheumatoid (2) · Endometriosis (1) · Pelvic Pain (1)
Astellas Pharma Europe B.V. (4) · Astellas Pharma Global Development, Inc. (1) · Astellas Pharma Inc (1)
Germany (2) · Japan (2) · United Kingdom (2) · Belgium (1) · Bulgaria (1) · France (1) · Hungary (1) · Moldova (1) · Poland (1) · Romania (1) · Ukraine (1)
2016 (1)